US 11753644
Compounds and methods for reducing IFNAR1 expression
granted A61KA61K31/713
Quick answer
US patent 11753644 (Compounds and methods for reducing IFNAR1 expression) held by Ionis Pharmaceuticals, Inc. expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K31/713